BARIATRIC SURGERY IN LIVER CIRRHOSIS: A COMPREHENSIVE REVIEW OF CURRENT EVIDENCE
Abstract
Background: The global epidemic of obesity and metabolic dysfunction-associated steatotic liver disease (MASLD) has led to an increasing prevalence of metabolic dysfunction-associated steatohepatitis (MASH)-related cirrhosis. Bariatric surgery has emerged as a potentially transformative intervention for carefully selected patients with obesity and liver cirrhosis.
References
1. Aminian, Ali et al. “Long-term liver outcomes after metabolic surgery in compensated cirrhosis due to metabolic dysfunction-associated steatohepatitis.” Nature medicine vol. 31,3 (2025): 988-995. doi:10.1038/s41591-024-03480-y
2. Mendoza, Yuly P et al. “Risks and Rewards of Bariatric Surgery in Advanced Chronic Liver Diseases.” Seminars in liver disease vol. 41,4 (2021): 448-460. doi:10.1055/s-0041-1731705
3. Cleveland Clinic. "Weight-loss surgery lowers risk of developing complications of liver disease in patients with cirrhosis and obesity." ScienceDaily. ScienceDaily, 27 January 2025. www.sciencedaily.com/releases/2025/01/250127124325.htm
4. Rouillard, Nicholas A et al. “Bariatric surgery reduces long-term mortality in patients with metabolic dysfunction-associated steatotic liver disease and cirrhosis.” Clinical and molecular hepatology vol. 31,1 (2025): 227-239. doi:10.3350/cmh.2024.0564
5. Goh, George Boon-Bee et al. “Considerations for bariatric surgery in patients with cirrhosis.” World journal of gastroenterology vol. 24,28 (2018): 3112-3119. doi:10.3748/wjg.v24.i28.3112
6. Zeng, Jing, and Jian-Gao Fan. “A leap in the dark: Bariatric surgery for treatment of metabolic dysfunction-associated steatotic liver disease related cirrhosis: Editorial on "Bariatric surgery reduces long-term mortality in patients with metabolic dysfunction-associated steatotic liver disease and cirrhosis".” Clinical and molecular hepatology vol. 31,2 (2025): 610-614. doi:10.3350/cmh.2024.1099
7. Mahawar, Kamal K et al. “Routine Liver Biopsy During Bariatric Surgery: an Analysis of Evidence Base.” Obesity surgery vol. 26,1 (2016): 177-81. doi:10.1007/s11695-015-1916-z
8. Tasabehji D, Saleh S, Mokadem M. Impact of Bariatric Surgery and Endoscopic Therapies on Liver Health in Metabolic Dysfunction-Associated Steatotic Liver Disease: A Review. Journal of Clinical Medicine. 2025; 14(12):4012. https://doi.org/10.3390/jcm14124012
9. Rouillard, Nicholas A et al. “Correspondence to editorial on "Bariatric surgery reduces long-term mortality in patients with metabolic dysfunction-associated steatotic liver disease and cirrhosis".” Clinical and molecular hepatology vol. 31,2 (2025): e173-e175. doi:10.3350/cmh.2025.0001
10. Seyedi, Arsalan et al. “Impact of bariatric surgery on liver fibrosis indices among type 2 diabetes patients in a national cohort.” Scientific reports vol. 15,1 1235. 7 Jan. 2025, doi:10.1038/s41598-025-85427-y
11. Jan, Ahmad et al. “A Systematic Review of Bariatric Surgery in Patients with Liver Cirrhosis.” Obesity surgery vol. 25,8 (2015): 1518-26. doi:10.1007/s11695-015-1727-2
12. Agarwal, Lokesh et al. “Bariatric Surgery in Nonalcoholic Fatty Liver Disease (NAFLD): Impact Assessment Using Paired Liver Biopsy and Fibroscan.” Obesity surgery vol. 31,2 (2021): 617-626. doi:10.1007/s11695-020-04977-4
13. Khajeh, Elias et al. “Outcomes of bariatric surgery in patients with obesity and compensated liver cirrhosis.” Surgery for obesity and related diseases : official journal of the American Society for Bariatric Surgery vol. 18,6 (2022): 727-737. doi:10.1016/j.soard.2022.03.011
14. Wang, Guocheng et al. “Impacts of bariatric surgery on adverse liver outcomes: a systematic review and meta-analysis.” Surgery for obesity and related diseases : official journal of the American Society for Bariatric Surgery vol. 19,7 (2023): 717-726. doi:10.1016/j.soard.2022.12.025
15. Shimizu, Hideharu et al. “Bariatric surgery in patients with liver cirrhosis.” Surgery for obesity and related diseases : official journal of the American Society for Bariatric Surgery vol. 9,1 (2013): 1-6. doi:10.1016/j.soard.2012.07.021
16. Bai, Jie et al. “Bariatric Surgery is Effective and Safe for Obese Patients with Compensated Cirrhosis: A Systematic Review and Meta-Analysis.” World journal of surgery vol. 46,5 (2022): 1122-1133. doi:10.1007/s00268-021-06382-z
17. Mendoza, Yuly P et al. “Risks and Rewards of Bariatric Surgery in Advanced Chronic Liver Diseases.” Seminars in liver disease vol. 41,4 (2021): 448-460. doi:10.1055/s-0041-1731705
18. Agarwal, Lokesh et al. “Safety of metabolic and bariatric surgery in obese patients with liver cirrhosis: a systematic review and meta-analysis.” Surgery for obesity and related diseases : official journal of the American Society for Bariatric Surgery vol. 17,3 (2021): 525-537. doi:10.1016/j.soard.2020.11.004
19. Patton, Heather et al. “AGA Clinical Practice Update on Bariatric Surgery in Cirrhosis: Expert Review.” Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association vol. 19,3 (2021): 436-445. doi:10.1016/j.cgh.2020.10.034
20. Mehdorn, A S et al. “Bariatric surgery in liver cirrhosis.” Frontiers in surgery vol. 9 986297. 15 Dec. 2022, doi:10.3389/fsurg.2022.986297
21. Cleveland Clinic. Metabolic Dysfunction-Associated Steatohepatitis (MASH). 2023.
22. Lassailly, Guillaume et al. “Resolution of Metabolic Dysfunction-associated Steatohepatitis With No Worsening of Fibrosis After Bariatric Surgery Improves 15-year Survival: A Prospective Cohort Study.” Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association, S1542-3565(24)01078-4. 19 Dec. 2024, doi:10.1016/j.cgh.2024.10.025
23. Allen, Alina M et al. “Guideline-based management of metabolic dysfunction-associated steatotic liver disease in the primary care setting.” Postgraduate medicine vol. 136,3 (2024): 229-245. doi:10.1080/00325481.2024.2325332
24. Ahmed, Saleem et al. “Outcomes of Bariatric Surgery in Patients with Liver Cirrhosis: a Systematic Review.” Obesity surgery vol. 31,5 (2021): 2255-2267. doi:10.1007/s11695-021-05289-x
25. Sandireddy, Reddemma et al. “Systemic impacts of metabolic dysfunction-associated steatotic liver disease (MASLD) and metabolic dysfunction-associated steatohepatitis (MASH) on heart, muscle, and kidney related diseases.” Frontiers in cell and developmental biology vol. 12 1433857. 16 Jul. 2024, doi:10.3389/fcell.2024.1433857
26. Novo Nordisk. Metabolic dysfunction-associated steatohepatitis (MASH).
27. European Association for the Study of the Liver (EASL) et al. “EASL-EASD-EASO Clinical Practice Guidelines on the management of metabolic dysfunction-associated steatotic liver disease (MASLD).” Journal of hepatology vol. 81,3 (2024): 492-542. doi:10.1016/j.jhep.2024.04.031
28. European Association for the Study of the Liver (EASL) et al. “EASL-EASD-EASO Clinical Practice Guidelines on the Management of Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD).” Obesity facts vol. 17,4 (2024): 374-444. doi:10.1159/000539371
29. Wikipedia Contributors. Metabolic dysfunction–associated steatotic liver disease. Wikipedia. 2025.
30. Alkhouri N, et al. Bariatric surgery significantly reduced major adverse liver outcomes in MASH cirrhosis. Healio Gastroenterology. 2024.
31. Wågen Hauge, Jostein et al. “Effect of gastric bypass versus sleeve gastrectomy on the remission of type 2 diabetes, weight loss, and cardiovascular risk factors at 5 years (Oseberg): secondary outcomes of a single-centre, triple-blind, randomised controlled trial.” The lancet. Diabetes & endocrinology vol. 13,5 (2025): 397-409. doi:10.1016/S2213-8587(24)00396-6
32. Howard, Ryan et al. “Comparative Safety of Sleeve Gastrectomy and Gastric Bypass Up to 5 Years After Surgery in Patients With Severe Obesity.” JAMA surgery vol. 156,12 (2021): 1160-1169. doi:10.1001/jamasurg.2021.4981
33. Courcoulas, Anita P et al. “Reduction in Long-term Mortality After Sleeve Gastrectomy and Gastric Bypass Compared to Nonsurgical Patients With Severe Obesity.” Annals of surgery vol. 277,3 (2023): 442-448. doi:10.1097/SLA.0000000000005155
34. Holmberg D, et al. Mortality risk higher with sleeve gastrectomy vs. gastric bypass for adults with diabetes. Diabetes Care. 2022;45(11):2552-2560. doi:10.2337/dc22-0485.
35. Khalaj, Alireza et al. “Two-year outcomes of sleeve gastrectomy versus gastric bypass: first report based on Tehran obesity treatment study (TOTS).” BMC surgery vol. 20,1 160. 20 Jul. 2020, doi:10.1186/s12893-020-00819-3
36. Holmberg, Dag et al. “Long-term Survival After Sleeve Gastrectomy Versus Gastric Bypass in a Binational Cohort Study.” Diabetes care vol. 45,9 (2022): 1981-1986. doi:10.2337/dc22-0485
37. Poelemeijer, Youri Q M et al. “Gastric Bypass Versus Sleeve Gastrectomy: Patient Selection and Short-term Outcome of 47,101 Primary Operations From the Swedish, Norwegian, and Dutch National Quality Registries.” Annals of surgery vol. 272,2 (2020): 326-333. doi:10.1097/SLA.0000000000003279
38. Alaidaroos, Omar et al. “Long-Term Outcomes of Sleeve Gastrectomy Versus Gastric Bypass.” Cureus vol. 16,11 e72961. 4 Nov. 2024, doi:10.7759/cureus.72961
39. Singhal, Rishi et al. “30-day morbidity and mortality of sleeve gastrectomy, Roux-en-Y gastric bypass and one anastomosis gastric bypass: a propensity score-matched analysis of the GENEVA data.” International journal of obesity (2005) vol. 46,4 (2022): 750-757. doi:10.1038/s41366-021-01048-1
40. Sakurai, Yosuke et al. “Comparative survival of sleeve gastrectomy versus Roux-en-Y gastric bypass in adults with obesity: a systematic review and meta-analysis.” Surgery for obesity and related diseases : official journal of the American Society for Bariatric Surgery vol. 21,5 (2025): 559-569. doi:10.1016/j.soard.2024.11.016
41. Adams, Ted D et al. “Weight and Metabolic Outcomes 12 Years after Gastric Bypass.” The New England journal of medicine vol. 377,12 (2017): 1143-1155. doi:10.1056/NEJMoa1700459
42. Courcoulas, Anita P et al. “Seven-Year Weight Trajectories and Health Outcomes in the Longitudinal Assessment of Bariatric Surgery (LABS) Study.” JAMA surgery vol. 153,5 (2018): 427-434. doi:10.1001/jamasurg.2017.5025
43. Peterli, Ralph et al. “Laparoscopic Sleeve Gastrectomy Versus Roux-Y-Gastric Bypass for Morbid Obesity-3-Year Outcomes of the Prospective Randomized Swiss Multicenter Bypass Or Sleeve Study (SM-BOSS).” Annals of surgery vol. 265,3 (2017): 466-473. doi:10.1097/SLA.0000000000001929
44. Schauer, Philip R et al. “Bariatric Surgery versus Intensive Medical Therapy for Diabetes - 5-Year Outcomes.” The New England journal of medicine vol. 376,7 (2017): 641-651. doi:10.1056/NEJMoa1600869
45. Arterburn, David E et al. “Benefits and Risks of Bariatric Surgery in Adults: A Review.” JAMA vol. 324,9 (2020): 879-887. doi:10.1001/jama.2020.12567
